TACTILE SYSTEMS TECHNOLOGY INC financials

  1. Home
  2. Financials
  3. TCMD
TCMD CIK 0001027838

Source: EDGAR filings · Built 2026-06-02T04:09:02Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 40.43M 38.26M 33.53M 3.43M 528.00K 735.00K
EBITDA 35.92M 28.97M 24.58M -6.49M 1.92M -834.00K
Working Capital 124.21M 136.86M 104.24M 55.43M 79.09M 96.90M
Net Debt -67.49M -49.26M -10.66M 50.30M 52.38M -26.46M
Gross Margin 75.91% 73.96% 71.11% 71.31% 71.24% 70.97%
Operating Margin 8.89% 7.57% 6.57% -5.17% -0.85% -1.94%
Net Margin 5.79% 5.79% 10.39% -7.24% -5.68% -0.33%
Return on Equity (ROE) 8.72% 7.83% 14.73% -14.72% -9.21% -0.50%
Return on Assets (ROA) 6.97% 5.69% 10.13% -7.01% -4.84% -0.36%
Current Ratio 4.03× 4.36× 3.54× 1.86× 3.29× 4.63×
Debt-to-Equity 0.07× 0.21× 0.26× 0.59× 0.63× 0.17×
Effective Tax Rate 39.10% 27.80% -80.82% -15.47% -415.09% 72.58%
Cash Conversion Ratio 2.24× 2.40× 1.26× -0.29× -0.22× -4.51×
Accruals Ratio -0.09× -0.08× -0.03× -0.09× -0.06× -0.02×
SBC % of Revenue 2.54% 2.67% 2.75% 3.89% 4.89% 5.71%
CapEx Coverage 17.99× 17.00× 15.43× 2.93× 1.25× 1.36×
Free Cash Flow Per Share $1.74 $1.59 $1.45 $0.17 $0.03 $0.04

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 35.37× 24.47× 11.63× — — —
P/FCF 16.71× 10.81× 9.88× 67.17× 710.07× 1182.63×
FCF Yield 5.98% 9.25% 10.12% 1.49% 0.14% 0.08%
EV / EBITDA 16.24× 12.42× 13.30× — 224.42× —
P/S 1.97× 1.40× 1.23× 0.94× 1.82× 4.68×
P/B 2.97× 1.89× 1.74× 1.92× 2.95× 7.02×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 329.52M 292.98M 274.42M 246.78M 208.06M 187.13M
Cost of Revenue 79.38M 76.30M 79.29M 70.81M 59.84M 54.32M
Gross Profit 250.15M 216.69M 195.13M 175.98M 148.21M 132.81M
Research and Development Expense 8.48M 8.83M 7.82M 7.09M 5.66M 5.26M
Operating Expenses 220.87M 194.51M 177.09M 188.73M 149.97M 136.44M
Operating Income (Loss) 29.28M 22.18M 18.04M -12.76M -1.76M -3.63M
Income Tax Expense (Benefit) 12.25M 6.53M -12.74M 2.39M 9.52M -1.64M
Net Income (Loss) Attributable to Parent 19.09M 16.96M 28.52M -17.87M -11.81M -620.00K
Earnings Per Share, Basic $0.83 $0.71 $1.24 $-0.89 $-0.60 $-0.03
Weighted Average Number of Shares Outstanding, Basic 22.87M 23.88M 22.93M 20.07M 19.72M 19.35M
Earnings Per Share, Diluted $0.82 $0.70 $1.23 $-0.89 $-0.60 $-0.03
Weighted Average Number of Shares Outstanding, Diluted 23.30M 24.14M 23.18M 20.07M 19.72M 19.35M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 83.45M 94.37M 61.03M 21.93M 28.23M 47.85M
Assets, Current 165.17M 177.56M 145.29M 119.76M 113.55M 123.61M
Assets 273.94M 297.92M 281.44M 255.00M 244.27M 174.09M
Long-term Debt 0 — — — — —
Liabilities, Current 40.96M 40.70M 41.06M 64.33M 34.46M 26.71M
Liabilities 55.04M 81.33M 87.80M 133.60M 116.04M 49.34M
Stockholders' Equity Attributable to Parent 218.90M 216.60M 193.64M 121.40M 128.23M 124.75M
Common Stock, Shares, Outstanding 22.44M 23.88M 23.60M 20.25M 19.88M 19.49M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 42.81M 40.66M 35.85M 5.21M 2.63M 2.79M
Payments to Acquire Property, Plant, and Equipment 2.38M 2.39M 2.32M 1.78M 2.10M 2.06M
Net Cash Provided by (Used in) Investing Activities -2.54M -2.50M -2.48M -1.91M -82.18M 20.18M
Payments for Repurchase of Common Stock 26.56M 3.51M — — — —
Net Cash Provided by (Used in) Financing Activities -51.20M -4.82M 5.73M -9.60M 59.93M 2.11M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (TCMD CIK 0001027838), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ALNT

ALLIENT INC

GALT

GALECTIN THERAPEUTICS INC.

PLSE

Pulse Biosciences, Inc.